Introduction
VeriOsteo OP is the first AI-assisted screening software for bone mineral density (BMD) abnormalities approved by Taiwan FDA. By analyzing chest X-ray images, it predicts the BMD, calculates the T-score from the BMD, and automatically outputs a recommendation on BMD abnormalities with 90% accuracy. This information assists healthcare professionals in assessing the risk of BMD abnormalities, enabling them to make informed decisions regarding referrals. VeriOsteo OP provides a more convenient option for individuals seeking to screen for BMD abnormalities.
Features / strengths
1. Screening accuracy is 90%
2. Batch analysis of multiple X-ray images
3. Personalized reports with X-ray images, BMD, T-scores, Z-scores and AI analysis
4. Data management for easy search and report retrieval
Specification in detail
Supporting document
